Vaso Corporation appointed Shaun McMeans as a Class III director and member of the audit committee, effective July 23, 2026, strengthening governance with a designated financial expert on the board. McMeans currently serves as chief financial officer of Nabsys and previously held the CFO role at HTG Molecular Diagnostics, along with senior finance positions at several companies. As part of his board package, he will receive pro-rated non-employee director compensation and a one-time grant of 100,000 shares of Vaso common stock. The move aligns board incentives with shareholder interests as the company continues to expand its leadership and governance framework. Vaso describes itself as a leading MedTech company with segments in IT, professional sales services, and equipment. These appointments come amid ongoing communications from multiple outlets detailing McMeans’s qualifications and the company’s strategic initiatives.